Literature DB >> 18026633

Neurotoxocarosis.

Josef Finsterer1, Herbert Auer.   

Abstract

Infection of humans with embryonated eggs of Toxocara canis (larva migrans) remains asymptomatic, or results in covert or common toxocarosis, visceral larva migrans syndrome, or ophthalmologic and neurologic impairment. Though neurological manifestations of Toxocara canis larvae are rare, toxocarosis remains an important differential diagnosis of various neurological disorders. Manifestations of the central nervous system are dementia, meningo-encephalitis, myelitis, cerebral vasculitis, epilepsy, or optic neuritis. Manifestations of the peripheral nervous system comprise radiculitis, affection of cranial nerves, or musculo-skeletal involvement. If toxocarosis is neglected, ignored, or refused as a differential of these abnormalities, it may be easily overlooked for years. Early recognition and treatment of the infection is, however, of paramount importance since it reduces morbidity and mortality and the risk of secondary superinfection. Like the visceral manifestations, neurological manifestations of toxocarosis are treated by benzimidazole components, most frequently albendazole, corticosteroids, or diethylcarbamazine. If detected and treated early, the prognosis of neurological manifestations of toxocarosis is favourable.

Entities:  

Mesh:

Year:  2007        PMID: 18026633     DOI: 10.1590/s0036-46652007000500002

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  40 in total

1.  Severe meningoencephalomyelitis due to CNS-Toxocarosis.

Authors:  Oliver C Singer; Frauke Conrad; Kolja Jahnke; Elke Hattingen; Herbert Auer; Helmuth Steinmetz
Journal:  J Neurol       Date:  2010-11-05       Impact factor: 4.849

2.  Seroprevalence of human toxocariasis in Denmark.

Authors:  Christen R Stensvold; Jakob Skov; Lone N Møller; Per M Jensen; Christian M O Kapel; Eskild Petersen; Henrik V Nielsen
Journal:  Clin Vaccine Immunol       Date:  2009-07-29

Review 3.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Parasitoses with central nervous system involvement.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Wien Med Wochenschr       Date:  2014-10-09

Review 5.  Neurotoxocariasis: a systematic literature review.

Authors:  S Deshayes; J Bonhomme; Arnaud de La Blanchardière
Journal:  Infection       Date:  2016-03-23       Impact factor: 3.553

6.  Toxocara canis larvae reinfecting BALB/c mice exhibit accelerated speed of migration to the host CNS.

Authors:  Petra Kolbeková; David Větvička; Jan Svoboda; Karl Skírnisson; Markéta Leissová; Martin Syrůček; Helena Marečková; Libuše Kolářová
Journal:  Parasitol Res       Date:  2011-05-03       Impact factor: 2.289

7.  Molecular diagnosis of an ocular toxocariasis patient in Vietnam.

Authors:  Nguyen Van De; Nguyen Vu Trung; Le Van Duyet; Jong-Yil Chai
Journal:  Korean J Parasitol       Date:  2013-10-31       Impact factor: 1.341

8.  Meningitis by Toxocara canis after ingestion of raw ostrich liver.

Authors:  Young Noh; Sung-Tae Hong; Ji Young Yun; Hong-Kyun Park; Jung-Hwan Oh; Young Eun Kim; Beom S Jeon
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

9.  Seroprevalence of anti-Toxocara antibody among multiple sclerosis patients: a case-control study.

Authors:  Nastaran Khalili; Neda Khalili; Ali Nickhah; Bahman Khalili
Journal:  J Parasit Dis       Date:  2019-10-29

Review 10.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.